Surrozen Stock Quote SRZN - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

10.4495

Bid

4.01

Ask

10.45

Volume

15,370

9.6032 Day's Range 10.4495

4.50 52 Week Range 16.19

Market Cap

21.301M

Previous Close

10.2899

Open

10.15

Last Trade

10.35

Last Trade Time

Financial Volume

$ 154,316

VWAP

10.0401

Average Volume (3m)

15,965

Shares Outstanding

2,038,336

Dividend Yield

PE Ratio

-0.49

Earnings Per Share (EPS)

-21.12

Revenue

Net Profit

-43.04M

Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS). Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.surrozen.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Surrozen Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SRZN. The last closing price for Surrozen was $10.29. Over the last year, Surrozen shares have traded in a share price range of $ 4.50 to $ 16.19.

Surrozen currently has 2,038,336 shares outstanding. The market capitalization of Surrozen is $21.30 million. Surrozen has a price to earnings ratio (PE ratio) of -0.49.

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting

In preclinical models of cornea endothelial dystrophies, a Surrozen antibody-based Wnt mimetic reduced corneal edema and stimulated endothelial cell proliferation in the corneaSurrozen’s antibody...

Surrozen Provides First Quarter 2024 Financial Results and Business Update

SZN-043 Phase 1a clinical trial results to be presented at the 2024 European Association for the Study of the Liver (EASL) in Milan Preclinical data from ARVO 2024 demonstrate the promise of a...

Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis

In a preclinical model of pulmonary fibrosis, a Surrozen antibody-based SWAP platform molecule decreased pulmonary inflammation and fibrosis and improved lung function Surrozen Wnt mimetic SWAP...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.1995	1.94634146341	10.25	10.4584	9.55	13833	10.24887315	CS
4	0.7895	8.17287784679	9.66	11	8.14	10725	9.76139214	CS
12	-1.0805	-9.37120555074	11.53	16.19	8.14	15965	11.25350618	CS
26	5.108	95.6285687541	5.3415	16.19	5.2815	33496	8.39033385	CS
52	2.1455	25.8369460501	8.304	16.19	4.5	69848	8.54924595	CS
156	-132.8005	-92.7054101222	143.25	210	4.5	178781	31.16752391	CS
260	-132.8005	-92.7054101222	143.25	210	4.5	178781	31.16752391	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CTNTCheetah Net Supply Chain Service Inc	$ 6.58 (452.94%)	49.58M
FFIEFaraday Future Intelligent Electric Inc	$ 0.2849 (367.05%)	1.57B
MTCMMTec Inc	$ 9.10 (87.63%)	4.22M
HOLOMicroCloud Hologram Inc	$ 3.2201 (61.01%)	105.54M
SPWRSunPower Corporation	$ 4.39 (59.64%)	137.68M
AUGXAugmedix Inc	$ 1.14 (-51.28%)	13.06M
NOTVInotiv Inc	$ 2.12 (-49.16%)	4.02M
SHIMShimmick Corporation	$ 2.395 (-34.20%)	235.69k
AKYAAkoya BioSciences Inc	$ 2.90 (-29.61%)	2.21M
EASTEastside Distilling Inc	$ 1.0777 (-27.67%)	208.9k
FFIEFaraday Future Intelligent Electric Inc	$ 0.2849 (367.05%)	1.57B
CRKNCrown Electrokinetics Corporation	$ 0.0476 (3.93%)	390.01M
GWAVGreenwave Technology Solutions Inc	$ 0.0443 (6.24%)	238.8M
PLUGPlug Power Inc	$ 3.445 (19.20%)	203.42M
SINTSiNtx Technologies Inc	$ 0.054 (39.18%)	157.36M